Fate Therapeutics (FATE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -173,387 | -98,149 | -66,598 | -42,952 | -33,462 |
| Depreciation Amortization | 7,873 | 2,450 | 987 | 1,027 | 1,191 |
| Accounts receivable | -5,515 | 500 | -500 | N/A | N/A |
| Other Working Capital | -12,773 | 3,640 | 1,744 | 2,083 | 1,180 |
| Other Operating Activity | 144,573 | 8,384 | 25,717 | 3,025 | 1,268 |
| Operating Cash Flow | $-39,229 | $-83,175 | $-38,650 | $-36,817 | $-29,823 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -156,144 | -150,058 | 1,840 | -8,471 | -3,675 |
| PPE Investments | -4,932 | -7,395 | -2,303 | -1,725 | -439 |
| Investing Cash Flow | $-161,076 | $-157,453 | $-463 | $-10,196 | $-4,114 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 15,000 | 0 |
| Debt Repayment | N/A | -15,000 | N/A | -10,764 | -7,689 |
| Common Stock Issued | 282,348 | 164,928 | 137,270 | 43,346 | 29,035 |
| Other Financing Activity | 490 | 0 | 3,510 | -226 | 36,391 |
| Financing Cash Flow | $282,838 | $149,928 | $140,780 | $47,356 | $57,737 |
| Beginning Cash Position | 100,041 | 190,741 | 89,074 | 88,731 | 64,931 |
| End Cash Position | 182,574 | 100,041 | 190,741 | 89,074 | 88,731 |
| Net Cash Flow | $82,533 | $-90,700 | $101,667 | $343 | $23,800 |
| Free Cash Flow | |||||
| Operating Cash Flow | -39,229 | -83,175 | -38,650 | -36,817 | -29,823 |
| Capital Expenditure | -4,932 | -7,395 | -2,303 | -1,725 | -457 |
| Free Cash Flow | -44,161 | -90,570 | -40,953 | -38,542 | -30,280 |